{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:35:08Z","timestamp":1780598108293,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007381"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007381"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015974"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015974"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["17-28518A"],"award-info":[{"award-number":["17-28518A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajpath.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T01:55:35Z","timestamp":1655862935000},"page":"1321-1335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis"],"prefix":"10.1016","volume":"192","author":[{"given":"Ximena M.","family":"Muresan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-4064","authenticated-orcid":false,"given":"Eva","family":"Slab\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-8546","authenticated-orcid":false,"given":"Ji\u0159ina","family":"Proch\u00e1zkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Dr\u00e1pela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-4434","authenticated-orcid":false,"given":"Radek","family":"Fedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"P\u00edckov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-8689","authenticated-orcid":false,"given":"Ond\u0159ej","family":"Vacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e1chel","family":"V\u00edchov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-6497","authenticated-orcid":false,"given":"Tereza","family":"Such\u00e1nkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-1720","authenticated-orcid":false,"given":"Jan","family":"Bouchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"K\u00fcrf\u00fcrstov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-5179","authenticated-orcid":false,"given":"Milan","family":"Kr\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-3899","authenticated-orcid":false,"given":"Tereza","family":"Hul\u00ednov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek P.","family":"S\u00fdkora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"\u0160tudent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"Hejret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0324-4804","authenticated-orcid":false,"given":"Wytske M.","family":"van Weerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Puhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"Pustka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-0904","authenticated-orcid":false,"given":"David","family":"Pot\u011b\u0161il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-5548","authenticated-orcid":false,"given":"Zbyn\u011bk","family":"Zdr\u00e1hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Culig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-8150","authenticated-orcid":false,"given":"Karel","family":"Sou\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2022.05.009_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2022.05.009_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.euf.2019.01.016","article-title":"Biological evolution of castration-resistant prostate cancer","volume":"5","author":"Davies","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ajpath.2022.05.009_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1535-7163.MCT-11-0289","article-title":"Identification of docetaxel resistance genes in castration-resistant prostate cancer","volume":"11","author":"Marin-Aguilera","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajpath.2022.05.009_bib4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/cancers12071752","article-title":"Immunotherapy in prostate cancer","volume":"12","author":"Fay","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2022.05.009_bib5","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/1078-0432.CCR-14-3145","article-title":"TLR9-targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate cancer patients","volume":"21","author":"Hossain","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3389\/fimmu.2018.01188","article-title":"The pathologic role of toll-like receptor 4 in prostate cancer","volume":"9","author":"Ou","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/cancers12113227","article-title":"Toll-like receptor 3 in solid cancer and therapy resistance","volume":"12","author":"Muresan","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2022.05.009_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI134529","article-title":"TLR3 controls constitutive IFN-beta antiviral immunity in human fibroblasts and cortical neurons","volume":"131","author":"Gao","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2022.05.009_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcmm.12379","article-title":"TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in\u00a0vivo","volume":"19","author":"Gambara","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2022.05.009_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/jir.2018.0166","article-title":"Poly(I:C)-mediated death of human prostate cancer cell lines is induced by interleukin-27 treatment","volume":"39","author":"Kourko","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib11","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M114.601625","article-title":"Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells","volume":"290","author":"Palchetti","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2022.05.009_bib12","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.21873\/anticanres.13747","article-title":"Linking infection and prostate cancer progression: toll-like receptor3 stimulation rewires glucose metabolism in prostate cells","volume":"39","author":"Magnifico","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib13","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib14","doi-asserted-by":"crossref","first-page":"59781","DOI":"10.18632\/oncotarget.10926","article-title":"Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide","volume":"7","author":"Hoefer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2022.05.009_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2016.251","article-title":"Loss of SLCO1B3 drives taxane resistance in prostate cancer","volume":"115","author":"de Morree","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2022.05.009_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjc.6604822","article-title":"Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer","volume":"100","author":"van Weerden","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2022.05.009_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2014.11.033","article-title":"Targeting the androgen receptor confers in\u00a0vivo cross-resistance between enzalutamide and docetaxel, but not cabazitaxel, in castration-resistant prostate cancer","volume":"67","author":"van Soest","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib18","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.4049\/jimmunol.0903559","article-title":"High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors","volume":"184","author":"Zhu","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajpath.2022.05.009_bib20","doi-asserted-by":"crossref","first-page":"36156","DOI":"10.18632\/oncotarget.5392","article-title":"Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells","volume":"6","author":"Slab\u00e1kov\u00e1","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2022.05.009_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006529","article-title":"A versatile viral system for expression and depletion of proteins in mammalian cells","volume":"4","author":"Campeau","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2022.05.009_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2022.05.009_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2022.05.009_bib24","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1158\/1078-0432.CCR-05-0585","article-title":"Molecular alterations in primary prostate cancer after androgen ablation therapy","volume":"11","author":"Best","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2022.05.009_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2022.05.009_bib27","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1158\/0008-5472.CAN-06-4040","article-title":"Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles","volume":"67","author":"Tamura","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/1471-2407-14-970","article-title":"PROGgeneV2: enhancements on the existing database","volume":"14","author":"Goswami","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2022.05.009_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","article-title":"Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study","volume":"2","author":"Ross-Adams","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ajpath.2022.05.009_bib30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/0008-5472.CAN-10-3490","article-title":"TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer","volume":"71","author":"Salaun","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib31","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.4049\/jimmunol.1400840","article-title":"Stimulation of the RIG-I\/MAVS pathway by polyinosinic:polycytidylic acid upregulates IFN-beta in airway epithelial cells with minimal costimulation of IL-8","volume":"195","author":"Dauletbaev","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib32","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1073\/pnas.1304610110","article-title":"Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RAR\u03b2 and tumor regression","volume":"110","author":"Galli","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2022.05.009_bib33","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.0902401","article-title":"TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types","volume":"184","author":"Galli","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib34","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/onc.2010.240","article-title":"Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells","volume":"29","author":"Gan","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2022.05.009_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00262-010-0931-0","article-title":"Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence","volume":"60","author":"Gonzalez-Reyes","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajpath.2022.05.009_bib36","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/carcin\/bgn149","article-title":"Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism","volume":"29","author":"Paone","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2022.05.009_bib37","doi-asserted-by":"crossref","first-page":"32617","DOI":"10.1074\/jbc.M112.387803","article-title":"Proteolytic processing regulates toll-like receptor 3 stability and endosomal localization","volume":"287","author":"Qi","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2022.05.009_bib38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.1202173","article-title":"Cleaved\/associated TLR3 represents the primary form of the signaling receptor","volume":"190","author":"Toscano","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib39","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2007-02-072934","article-title":"Key differences in TLR3\/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems","volume":"110","author":"Lundberg","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2022.05.009_bib40","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.oraloncology.2018.09.015","article-title":"Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells","volume":"86","author":"Chuang","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2014.06.002","article-title":"Tyrosine phosphorylation in toll-like receptor signaling","volume":"25","author":"Chattopadhyay","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajpath.2022.05.009_bib43","doi-asserted-by":"crossref","first-page":"ra50","DOI":"10.1126\/scisignal.2002581","article-title":"Epidermal growth factor receptor is essential for toll-like receptor 3 signaling","volume":"5","author":"Yamashita","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.ajpath.2022.05.009_bib44","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ncb2122","article-title":"Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells","volume":"12","author":"Astin","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajpath.2022.05.009_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/path.2292","article-title":"BMP-6 over-expression in prostate cancer is associated with increased Id-1\u00a0protein and a more invasive phenotype","volume":"214","author":"Darby","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1878-0261.12597","article-title":"Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer","volume":"14","author":"Hoflmayer","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41588-020-0643-0","article-title":"CTCF is dispensable for immune cell transdifferentiation but facilitates an acute inflammatory response","volume":"52","author":"Stik","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2022.05.009_bib49","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1074\/jbc.M117.784090","article-title":"Surface toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness","volume":"292","author":"Bugge","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2022.05.009_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","article-title":"Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2022.05.009_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","article-title":"HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone","volume":"77","author":"Day","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib52","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1002\/jcp.27459","article-title":"Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-beta signaling axis in paclitaxel-resistant colon cancer","volume":"234","author":"Zhao","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2022.05.009_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.12.016","article-title":"Cisplatin unleashes toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma","volume":"472","author":"Vanbervliet-Defrance","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2022.05.009_bib54","first-page":"1919","article-title":"Anti-tumor outcome evaluation against non-small cell lung cancer in\u00a0vitro and in\u00a0vivo using polyI:C as nucleic acid therapeutic agent","volume":"11","author":"Wu","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ajpath.2022.05.009_bib55","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/mc.22584","article-title":"Toll-like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF","volume":"56","author":"Matijevic Glavan","year":"2017","journal-title":"Mol Carcinog"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022001742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022001742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:39:18Z","timestamp":1778657958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944022001742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0002944022001742"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.05.009","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}